GlassScriptPhysician profile
David W Cohen
NPI 1922191568
$3,807.59
in general payments reported to CMS, 2019-2025
18 companies · $1,441 in 2025
The $1,441 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $658 · 2020: $91.73 · 2021: $45.64 · 2022: $111 · 2023: $165 · 2024: $1,295 · 2025: $1,441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,118 · Food and Beverage: $783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,117.88 |
| Food and Beverage | $783.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $2,489.55 | 2024-2025 | Aquabeam System |
| Boston Scientific Corporation | $390.36 | 2019-2025 | Spaceoar System |
| Astellas Pharma US INC | $183.80 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $166.69 | 2023-2025 | Gemtesa |
| Myriad Women'S Health, INC. | $89.01 | 2023 | Myrisk |
| Ferring Pharmaceuticals INC. | $76.25 | 2019 | |
| Abbvie INC. | $70.28 | 2023-2025 | Botox |
| Pfizer INC. | $58.59 | 2019-2022 | |
| Mallinckrodt Enterprises LLC | $42.72 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.17 | 2020 | |
| Shire North American Group INC | $32.06 | 2019 | |
| Bluewind Medical | $31.31 | 2024 | Revi |
| Organon LLC | $29.28 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.88 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $24.87 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $24.55 | 2019 | |
| Urovant Sciences INC | $23.65 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.